Premium
P4‐210: Safety, tolerability and pharmacokinetics of single‐ascending doses of bapineuzumab in Japanese patients with mild‐to‐moderate Alzheimer's disease
Author(s) -
Arai Heii,
Umemura Kazao,
Ichimiya Yosuke,
Iseki Eizo,
Eto Ko,
Shibata Nobuto,
Baba Hajime,
Tsuchiwata Shinichi,
Miyasato Moriyuki,
Ishikawa Norifumi
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.2233
Subject(s) - tolerability , medicine , placebo , pharmacokinetics , adverse effect , gastroenterology , cmax , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom